| Code No. | 566 | |
| Anti-CD117 (c-Kit) (Human) pAb | ||
| Price | ¥67,000 | |
| Size | 100 µL | |
| Availability (in Japan) | 10 or more
(In Japan at 00:05, May 21, 2026 in JST) |
|
| Clonality | Polyclonal | |
| Clone | Polyclonal | |
| Isotype (Immunized Animal) |
Rabbit IgG | |
| Applications | WB 1:1,000 IC 1:200 (Heat treatment is necessary for paraffin embedded sections.) IH 1:200 (Heat treatment is necessary for paraffin embedded sections.) |
|
| Immunogen (Antigen) |
Carrier protein conjugated synthetic peptide (C-terminal of c-kit gene product (K963)) | |
| Reactivity [Gene ID] | Human[3815] |
|
| Storage buffer | "PBS/50% glycerol, pH 7.2" | |
| Storage temp. | -20°C | |
| Conjugate | Unlabeled | |
| Manufacturer | MBL | |
| Alternative names | KIT proto-oncogene receptor tyrosine kinase | |
| Background | "c-Kit, also known as stem cell factor receptor, steel factor receptor or CD117 is classified as a type III receptor tyrosine kinase (RTK) belonging to the platelet-derived growth factor receptor subfamily. Binding of stem cell factor (SCF), known as c-Kit ligand to c-Kit, initiates autophosphorylation of the receptor, subsequently leading to promotes a signal transduction cascade through Ras-Raf-MAP kinase cascade, phosphatidylinositol- 3-kinase, src family kinases, and JAK/STAT pathways. The roles of c-Kit include maturation of hematopoietic and primordial germ cells precursors and melanocytes during embryonic development. In acute myeloid leukemia (AML), c-Kit has been proposed to play a functional role, and becomes target molecule for drug development." | |
| Related products | 566-H Anti-CD117 (c-Kit) (Human) pAb |
|
| Product category | Research area:Stem cell research Cancer Cell surface antigens | |
| Data | ![]() ![]() ![]() |
|
| Citations | Immunohistochemistry
|
|
Copyright (C)2015 Medical & Biological Laboratories Co., Ltd. All Rights Reserve